Grant: Doctoral Research Award: Canada Graduate Scholarships
University of Calgary
$105,000.00
Modeling Human Glioblastoma in the Context of the Extracellular Environment
EF 2020-21
Résumé
"I always like to have a glimmer of hopefulness, even in collapse" - Gordon Downie, Canadian singer-songwriter, activist, glioma patient.
Approximately 1000 Canadians a year are diagnosed with brain tumors, and those diagnosed with the most aggressive and fatal form of brain tumors called gliomas have an average survival of 18 months. Research in the past has primarily focused on identifying and targeting specific genetic mutations in the tumor. However, it is apparent that the environment surrounding the tumor can influence tumor growth, tumor spread into the brain, and drug resistance. The brain presents many challenges to glioma treatment, one of which is the unique environment in which gliomas grow, which contributes to poor patient outcomes. The interaction between tumor cells, surrounding normal brain tissue, immune cells, and the structural support of the tumor, the extracellular matrix (ECM) provides an environment that supports the progression and aggressiveness of glioma. The ECM, a 3-dimensional network of proteins, provides tissue-specific molecular and mechanical cues to the tumor. By isolating the ECM, we will determine the components of the glioma environment, study how cells grow and move within this environment, and how the ECM contributes to therapeutic failure. In addition, we will look at the influence of the ECM on immune cells located within the tumor environment. It has become abundantly clear through the failed use of the primary glioma chemotherapy, that directly targeting the tumor is insufficient. Therefore, targeting the glioma environment in addition to the tumor may be considered a better therapeutic strategy. Treating the environment may result in a switch from a tumor-promoting environment to a tumor-suppressing environment. Understanding and characterizing the glioma ECM, may provide unique opportunities to target the glioma environment in addition to targeting the tumor, leading to more successful patient outcomes.
Programme
Doctoral Research Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
439648
Name
Poole Alisha
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Modeling Human Glioblastoma in the Context of the Extracellular Environment
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Brain Cancer; Extracellular Matrix; Glioma; Microenvironment
Abstract
"I always like to have a glimmer of hopefulness, even in collapse" - Gordon Downie, Canadian singer-songwriter, activist, glioma patient.
Approximately 1000 Canadians a year are diagnosed with brain tumors, and those diagnosed with the most aggressive and fatal form of brain tumors called gliomas have an average survival of 18 months. Research in the past has primarily focused on identifying and targeting specific genetic mutations in the tumor. However, it is apparent that the environment surrounding the tumor can influence tumor growth, tumor spread into the brain, and drug resistance. The brain presents many challenges to glioma treatment, one of which is the unique environment in which gliomas grow, which contributes to poor patient outcomes. The interaction between tumor cells, surrounding normal brain tissue, immune cells, and the structural support of the tumor, the extracellular matrix (ECM) provides an environment that supports the progression and aggressiveness of glioma. The ECM, a 3-dimensional network of proteins, provides tissue-specific molecular and mechanical cues to the tumor. By isolating the ECM, we will determine the components of the glioma environment, study how cells grow and move within this environment, and how the ECM contributes to therapeutic failure. In addition, we will look at the influence of the ECM on immune cells located within the tumor environment. It has become abundantly clear through the failed use of the primary glioma chemotherapy, that directly targeting the tumor is insufficient. Therefore, targeting the glioma environment in addition to the tumor may be considered a better therapeutic strategy. Treating the environment may result in a switch from a tumor-promoting environment to a tumor-suppressing environment. Understanding and characterizing the glioma ECM, may provide unique opportunities to target the glioma environment in addition to targeting the tumor, leading to more successful patient outcomes.
Competitiondate
202011
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Poole, Alisha
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~